2010 annual financial data
Ernexa Therapeutics 2010 Net margin
Ernexa Therapeutics 2010 net margin with verified reported values.
Direct answer
Net margin was -1.58%.
Operating income was -325,000 USD and net income was -400,000 USD.
Operating cash flow was 2,831,000 USD.
Get free Ernexa Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 25,309,000 USD
- Operating income
- -325,000 USD
- Net income
- -400,000 USD
- Operating cash flow
- 2,831,000 USD